Relapsing polychondritis with Castleman-like lymphadenopathy: A case report

Clinical Rheumatology

Volumn 16, Issue 5, 1997, Pages 480-484

  Manganelli, P ^a   Quaini, F ^b   Olivetti, G ^b   Savini, M ^a   Pileri, S ^c  

^a ACADEMIC HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Castleman Like Lymphadenopathy; Relapsing Polychondritis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE; SMOOTH MUSCLE ANTIBODY;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS;

ADRENAL CORTEX HORMONES; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030821726     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238942     Document Type: Article

References (19)

1. Herman JH. Polychondritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology. Philadelphia, Saunders, 1993, 1400-11.
2. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 1976; 55: 193-215.
3. Frizzera G. Systemic Castleman's disease. Am J Surg Pathol 1991; 15: 192.
4. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, Katz SI. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978; 299: 1203-7.
5. Meyer O, Cyna J, Dryll A, Cywiner-Golenzer C, Wassef M, Ryckewaert A. Relapsing polychondritis. Pathogenic role of anti-native collagen type II antibodies. A case report with immunological and pathological studies. J Rheumatol 1981; 8: 820-4.
6. Svenson KL, Holmdahl R, Klareskog L, Wibell L, Sjoberg O, Klint-malm GB et al. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol 1984; 13: 329-33.
7. Riccieri V, Spadaro A, Taccari E, Zoppini A. A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol 1988; 6: 95-6.
8. Alsalameh S, Mollenhauer J, Scheuplein K, Stoss H, Kalden JR, Burkhardt H, et al. Preferential cellular and humoral immune reactivities to native and denaturated collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol 1993; 20: 1419-24.
9. Gibson GJ. Relapsing polychondritis. In "Lung disease in rheumatic disorders". Bailliére's Clin Rheum 1993; 7: 179-81.
10. Mendelson DS, Som PM, Crane R, Cohen BA, Spiera H. Relapsing polychondritis studied by computed tomography. Radiology 1985; 157: 489-90.
11. Goddard P, Cook P, Laszlo G, Glover SC. Relapsing polychondritis: report of an unusual case and a review of the literature. Br J Radiol 1991; 64: 1064-7.
12. Miller SB, Donlan CJ, Roth SB. Hodgkin's disease presenting as relapsing polychondritis. Arthritis Rheum 1974; 17: 598-602.
13. Frizzera G, Moran EM, Rappaport H. Angio-Immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med 1975; 59: 803-18.
14. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Thaeo L, Aozasa K, et al. Pathogenetic significance of interleukin-6 (IL-6/BSF2) in Castleman's disease. Blood 1989; 74: 1360-7.
15. Frizzera G. Castleman's Disease: more questions than answers. Hum Pathol 1985; 16: 202-5
16. Isaak BL, Liesegang TJ, Michet CJ Jr. Ocular and systemic findings in relapsing polychondritis. Ophthalmology 1986; 93: 681-9.
17. Michet CJ, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986; 104: 74-8.
18. ter Borg E-J, Piers A, Thijn CJP. Increased cartilaginous uptake on bone scintigraphy in a patient with relapsing polychondritis. Eur J Nucl Med 1988; 14: 427-8.
19. Kao C-H, Wang S-J, Yeh S-H. Radionuclide imaging of relapsing polychondritis. Clin Nucl Med 1992; 17: 397-8.